Page results
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
-
This page provides information about post procedural care following a diagnostic angiogram or endovascular treatment and possible complications that may occur.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
Information on parvovirus for patients with haemolytic anaemias.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This page provides general information about extreme lateral lumbar fusion and decompression (XLIF®).
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
File results
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0262 - Clinical trial participation